GE HealthCare Technologies (GEHC) Research & Development (2022 - 2026)

GE HealthCare Technologies has reported Research & Development for 5 years, with the latest figure at $345.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development changed 0.29% year-over-year to $345.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (down 5.18% YoY), and the FY2025 full-year result was $1.3 billion, down 3.89% from the prior year.
• Research & Development for Q1 2026 stood at $345.0 million, up from $323.0 million in the prior quarter.
• The five-year high for Research & Development was $345.0 million in Q1 2026, with the low at $238.0 million in Q1 2022.
• Historically, Research & Development has averaged $302.8 million across 5 years, with a median of $315.0 million in 2023.
• Annual changes were most pronounced in 2023 — Research & Development gained 23.85% — and 2025, when it decreased 7.65%.
• GE HealthCare Technologies' Research & Development stood at $271.0 million in 2022, then increased by 16.24% to $315.0 million in 2023, then increased by 9.21% to $344.0 million in 2024, then dropped by 6.1% to $323.0 million in 2025, then gained by 6.81% to $345.0 million in 2026.
• The last three Research & Development figures came in at $345.0 million (Q1 2026), $323.0 million (Q4 2025), and $292.0 million (Q3 2025), per Business Quant data.